beta -LACTAMYL VASOPRESSIN VlaANTAGONISTS

Novel 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives and 2-(azetidin-2-on-l-yl)alkoxyalkanoic acid derivatives are described for use in the treatment of disease states responsive to antagonism of the vasopressin Vla receptor. La présente invention concerne de nouveaux dérivés d'acide 2-(aze...

Full description

Saved in:
Bibliographic Details
Main Authors KOPPEL, GARY, A, LU, SHIFANG, BRUNS, ROBERT, F., JR, GUILLON, CHRISTOPHE, D., G, HEINDEL, NED, D, MILLER, MARVIN, J, SIMON, NEAL, G
Format Patent
LanguageEnglish
French
Published 17.04.2003
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Novel 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives and 2-(azetidin-2-on-l-yl)alkoxyalkanoic acid derivatives are described for use in the treatment of disease states responsive to antagonism of the vasopressin Vla receptor. La présente invention concerne de nouveaux dérivés d'acide 2-(azetidin-2-sur-1-yl)alcanedioïque destinés au traitement de maladies sensibles à l'antagonisme du récepteur Vla de vasopressine.
AbstractList Novel 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives and 2-(azetidin-2-on-l-yl)alkoxyalkanoic acid derivatives are described for use in the treatment of disease states responsive to antagonism of the vasopressin Vla receptor. La présente invention concerne de nouveaux dérivés d'acide 2-(azetidin-2-sur-1-yl)alcanedioïque destinés au traitement de maladies sensibles à l'antagonisme du récepteur Vla de vasopressine.
Author BRUNS, ROBERT, F., JR
KOPPEL, GARY, A
MILLER, MARVIN, J
HEINDEL, NED, D
GUILLON, CHRISTOPHE, D., G
LU, SHIFANG
SIMON, NEAL, G
Author_xml – fullname: KOPPEL, GARY, A
– fullname: LU, SHIFANG
– fullname: BRUNS, ROBERT, F., JR
– fullname: GUILLON, CHRISTOPHE, D., G
– fullname: HEINDEL, NED, D
– fullname: MILLER, MARVIN, J
– fullname: SIMON, NEAL, G
BookMark eNrjYmDJy89L5WTQTEotSVTQ9XF0DnH0jfRRCHMM9g8Icg0O9vRTCMtJdPQLcXT39_MMDgnmYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXx4f4GxgbGhiYG5o5GxsSoAQCGdCcr
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate ANTAGONISTES V1A DE VASOPRESSINE BETA-LACTAMYL
Edition 7
ExternalDocumentID WO03031407A2
GroupedDBID EVB
ID FETCH-epo_espacenet_WO03031407A23
IEDL.DBID EVB
IngestDate Fri Jul 19 15:55:41 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
French
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_WO03031407A23
Notes Application Number: WO2002US32433
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030417&DB=EPODOC&CC=WO&NR=03031407A2
ParticipantIDs epo_espacenet_WO03031407A2
PublicationCentury 2000
PublicationDate 20030417
PublicationDateYYYYMMDD 2003-04-17
PublicationDate_xml – month: 04
  year: 2003
  text: 20030417
  day: 17
PublicationDecade 2000
PublicationYear 2003
RelatedCompanies BRUNS, ROBERT, F., JR
KOPPEL, GARY, A
MILLER, MARVIN, J
HEINDEL, NED, D
SERENIX PHARMACEUTICALS, LLC
GUILLON, CHRISTOPHE, D., G
LU, SHIFANG
SIMON, NEAL, G
RelatedCompanies_xml – name: MILLER, MARVIN, J
– name: SIMON, NEAL, G
– name: HEINDEL, NED, D
– name: BRUNS, ROBERT, F., JR
– name: KOPPEL, GARY, A
– name: LU, SHIFANG
– name: SERENIX PHARMACEUTICALS, LLC
– name: GUILLON, CHRISTOPHE, D., G
Score 2.5757794
Snippet Novel 2-(azetidin-2-on-1-yl)alkanedioic acid derivatives and 2-(azetidin-2-on-l-yl)alkoxyalkanoic acid derivatives are described for use in the treatment of...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title beta -LACTAMYL VASOPRESSIN VlaANTAGONISTS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20030417&DB=EPODOC&locale=&CC=WO&NR=03031407A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQMbdMBdaqBqa6KSmmKbom5gbJuknGpsDsbppqaZCWaJqcYgDajezrZ-YRauIVYRrBxJAF2wsDPie0HHw4IjBHJQPzewm4vC5ADGK5gNdWFusnZQKF8u3dQmxd1GC9Y2Dn3NBczcXJ1jXA38XfWc3ZGdhvU_MLAp0QZQzsS5g7AotrVlAzGnTOvmuYE2hXSgFyleImyMAWADQtr0SIgSk1T5iB0xl285owA4cvdMIbyITmvWIRBs0koIsUdH0cnUMcfSN9FMIcg_3B4efppxCWk-joF-Lo7u_nGRwSLMqg6OYa4uyhC7QzHu7B-HB_hPOMxRhYgB3_VAkGBWBXKsXCIDUlLdUUWAknWiSZmCeBZj3NTROTzVKMDSUZpHCbI4VPUpqBC7woDXRmobkMA0tJUWmqLLByLUmSA4cKAPTAegA
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTkXnVwUp-FDsaLNsD0O6drXVfgxb63wqbZOBInO4iv--17A6X_QtJHC5HNwdv1zuF4BLOuCYVVWiMEaYolO1UHKNoLsTPlBnGSmYWnUj-0HPedTvpmTagNe6F0bwhH4JckT0qAL9vRTxerG-xLLE28rldf6CU-83djy05BodIzjvUtkaDceT0ApN2TQRt8nBQ8UQpSGWoAaG6w2KkFBApWRUdaUsfqcUewc2JyhtXu5Cg8_b0DLrn9fasOWvCt44XPnecg-uctRIUjzDjA3_2ZMSIwqF_dxASt4yI4iN2zBwozjahwt7HJuOgnumPwdMn8K1etoBNBH480OQEEqxvsrZjBNMwlk_12leVT0pyYoe07pH0PlbTue_xXNoObHvpZ4b3B_DtnigVvEX0hNolh-f_BQTbZmfCQt9A83qfOo
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=beta+-LACTAMYL+VASOPRESSIN+VlaANTAGONISTS&rft.inventor=KOPPEL%2C+GARY%2C+A&rft.inventor=LU%2C+SHIFANG&rft.inventor=BRUNS%2C+ROBERT%2C+F.%2C+JR&rft.inventor=GUILLON%2C+CHRISTOPHE%2C+D.%2C+G&rft.inventor=HEINDEL%2C+NED%2C+D&rft.inventor=MILLER%2C+MARVIN%2C+J&rft.inventor=SIMON%2C+NEAL%2C+G&rft.date=2003-04-17&rft.externalDBID=A2&rft.externalDocID=WO03031407A2